Free Trial
TSE:GEN

GeneNews (GEN) Stock Price, News & Analysis

GeneNews logo
C$0.15
+0.01 (+7.14%)
(As of 06/25/2019)

About GeneNews Stock (TSE:GEN)

Key Stats

Today's Range
C$0.14
C$0.15
50-Day Range
C$0.15
C$0.15
52-Week Range
C$0.03
C$0.21
Volume
473,147 shs
Average Volume
1.48 million shs
Market Capitalization
C$25.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada.

Receive GEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GeneNews and its competitors with MarketBeat's FREE daily newsletter.

GEN Stock News Headlines

GeneNews: Q1 Earnings Snapshot
This Bull Market Indicator called NVDA at $116
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
See More Headlines

GEN Stock Analysis - Frequently Asked Questions

GeneNews' stock was trading at C$0.15 at the beginning of 2024. Since then, GEN shares have increased by 0.0% and is now trading at C$0.15.
View the best growth stocks for 2024 here
.

Shares of GEN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that GeneNews investors own include Marathon Digital (MARA), Ocugen (OCGN), Spero Therapeutics (SPRO), StorageVault Canada (SVI), American Airlines Group (AAL), First Majestic Silver (AG) and Antibe Therapeutics (ATE).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Computer Software
CIK
N/A
Fax
N/A
Employees
2,700
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$234,592.00
Cash Flow
C$0.00 per share
Book Value
C($0.06) per share

Miscellaneous

Free Float
N/A
Market Cap
C$25.49 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (TSE:GEN) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners